4 results match your criteria: "1 Geha Mental Health Center[Affiliation]"
J Child Adolesc Psychopharmacol
September 2018
1 Geha Mental Health Center, Petah Tikva, Israel .
Objectives: Treatment with selective serotonin reuptake inhibitors (SSRIs) is common and is considered safe and effective in the treatment of anxiety and depressive disorders in pediatric populations. SSRI administration, however, is associated with adverse metabolic effects. The aim of this preliminary study was to evaluate the possible influence of a 6-month SSRI treatment on metabolic parameters in children and adolescents with depressive and/or anxiety disorders.
View Article and Find Full Text PDFJ Atten Disord
September 2019
1 Geha Mental Health Center, Petah Tikva, Israel.
This chart review study characterized demographic and clinical indicators of the need for hospitalization in preschoolers with ADHD. Medical records of preschoolers with (4th ed., text rev.
View Article and Find Full Text PDFJ Child Adolesc Psychopharmacol
March 2017
2 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel .
J Child Adolesc Psychopharmacol
November 2014
1 Geha Mental Health Center, Petach Tikva, Israel.
Objective: The purpose of this study was to determine if the known side effects of lithium in adults may be generalized to younger patients with psychiatric disorders.
Methods: A retrospective naturalistic study design was used. Data were collected from the database of a tertiary pediatric medical center covering the years 1994-2010.